Sesen Bio Inc (SESN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

245 FIRST STREET CAMBRIDGE, MA 02142

Eleven Biotherapeutics Inc provides pharmaceuticals products. The company designs, develops protein-based medicines to treat inflammatory conditions and coagulation disorders. Eleven Biotherapeutics serves pharmaceutical industry throughout the United States.

Data based on most recent fiscal year report
Market Cap39.788 Million Shares Outstanding31.83 Million Avg Volume1.122 Million
1-Yr BETA vs S&P TR Current Ratio6.52 Quick Ratio6.52
View SEC Filings from SESN instead.
Q2 2019 All Institutions Hedge Funds 1
To trade SESN now:
Filers who had this stock in their top 10: 2 0 (0.0%)
13F Filers holding this stock: 44 7 (0.72%)
Aggregate 13F shares on 06/30/2019: 29.04 Million 9.012 Million
Aggregate 13F shares on 03/31/2019: 18.702 Million 6.86 Million
Percent change: 55.28% 31.36%
Funds creating new positions: 13 4
Funds Adding to an existing position: 12 2
Funds closing out their position: 16 7
Funds reducing their position: 8 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SESN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DIXON WENDY L

  • Director
12,340 2019-09-30 1

LYNCH DANIEL

  • Director
391,277 2019-09-12 1

FORBES MONICA CHIEF FINANCIAL OFFICER

  • Officer
0 2019-08-26 2

ANDERSON KIRSTIN PRINCIPAL ACCOUNTING OFFICER

  • Officer
32,228 2019-08-26 1

SULLIVAN MARK GENERAL COUNSEL & SECRETARY

  • Officer
0 2019-08-01 2

LEVIN MARK J

  • Director
  • 10% Owner
5,962,202 2019-07-22 0

MACDONALD GLEN C CHIEF TECHNOLOGY OFFICER

  • Officer
0 2019-07-10 2

AFEYAN NOUBAR

  • Director
  • 10% Owner
0 2019-06-27 0

PFEFFER CARY

  • Director
0 2019-06-25 0

DUKER JAY S.

0 2019-06-25 1

HENDERSON JANE

  • Director
0 2019-06-19 1

DAN LESLIE

  • Director
0 2019-06-19 1

PERRY GREGORY D

  • Director
0 2019-06-05 0

BERRY DAVID A

  • Director
0 2019-05-22 0

TUBRIDY KAREN L SVP, CHIEF DEVELOPMENT OFFICER

  • Officer
55,324 2019-04-11 0

MCCABE JOHN J VICE PRESIDENT, FINANCE

  • Officer
0 2019-02-27 0

FITZGERALD RICHARD F CHIEF FINANCIAL OFFICER

  • Officer
0 2019-02-21 1

CANNELL THOMAS R PRESIDENT AND CEO

  • Officer
  • Director
0 2019-02-21 1

CHANEY PAUL G

  • Director
0 2019-02-01 0

KIM DENNIS CHIEF MEDICAL OFFICER

  • Officer
0 2018-12-03 2

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

STARR KEVIN P

TEPPER ROBERT I

LEVIN MARK J

  • 10% Owner
3,278,752 2018-08-30 0

CELNIKER ABBIE

  • Director
0 2018-06-12 0

HURLY STEPHEN A PRESIDENT AND CEO

  • Officer
  • Director
0 2018-06-12 0

GERTZ BARRY

  • Director
0 2017-05-19 0

DECILLIS ARTHUR CHIEF MEDICAL OFFICER

  • Officer
0 2017-04-03 0

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND 2007, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

AFEYAN NOUBAR

KANIA EDWIN M JR

  • 10% Owner
No longer subject to file 2016-09-22 0

CLAIRMARK INVESTMENTS LTD.

  • 10% Owner
3,582,328 2016-09-20 0

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

LEWIS JOSEPH

MVA INVESTORS, LLC

  • 10% Owner
No longer subject to file 2016-06-13 0

FURFINE ERIC STEVEN CHIEF SCIENTIFIC OFFICER

  • Officer
34,648 2015-12-28 0

JAFCO SUPER V3 INVESTMENT LIMITED PARTNERSHIP

  • 10% Owner
1,497,053 2015-10-16 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

  • 10% Owner
No longer subject to file 2015-04-07 0

STARR KEVIN P

TEPPER ROBERT I

  • 10% Owner
330,708 2014-02-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FORBES MONICA - Officer CHIEF FINANCIAL OFFICER

2019-08-26 A 280,000 a 280,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments